Industry

LYON, France–(BUSINESS WIRE)–PK MED, a French biotech company, privately owned, and established in 2019 by Truffle Capital, announced it has secured a non-dilutive DeepTech financing of € 1.5 million from Bpifrance. The funding will accelerate the company’s project PKM-02, an innovative cell-homing technology aiming to enhance bone marrow transplantation in several diseases with high unmet … [Read more…]

BOSTON—(BUSINESS WIRE)–Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of its common stock at a combined offering price to the public of … [Read more…]

BRANFORD, Conn.–(BUSINESS WIRE)–Azitra, Inc. (NYSE American: AZTR) (“Company”), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the pricing of a public offering of an aggregate of 6,665,000 shares of its common stock, and Class A warrants to purchase up to 13,330,000 shares of common stock, at a combined public … [Read more…]

THE WOODLANDS, Texas–(BUSINESS WIRE)–Curitec, LLC, the leader in high-quality wound care products, innovative technology, and robust educational resources, proudly announces the successful resolution of all issues with the Centers for Medicare Services (CMS), marking a significant milestone in our journey. “Throughout this challenging period, we remained steadfast in our commitment to delivering exceptional products and … [Read more…]

ONTARIO, Calif.–(BUSINESS WIRE)–First paragraph, first sentence of release dated July 19, 2024, conference call time should read: 1:00 p.m. (ET) (instead of 2:00 p.m. (ET)). The updated release reads: PRIME HEALTHCARE SERVICES, INC. SCHEDULES 2024 2ND QUARTER EARNINGS CONFERENCE CALL Prime Healthcare Services will host a conference call to provide a business update and review … [Read more…]

RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of the company’s common stock for the fourth quarter of 2024. Payment will be made on Oct. 7, 2024, to shareholders of record … [Read more…]

Report finds industry-wide risk signal amidst noise of 85 million transactions, showcasing power of Conflixis’ AI-enabled platform. DALLAS & NEW YORK–(BUSINESS WIRE)–Conflixis, a new conflicts of interest risk management technology provider, today released its inaugural 2024 Open Payments Report, revealing critical insights into the financial relationships between healthcare providers and the pharmaceutical and medical device … [Read more…]

This study aims to enhance U.S. public health preparedness through Walgreens community pharmacy network, improving access and diversity in clinical trials via a $25m award DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens today announced it received a project award valued up to $25 million through the Rapid Response Partnership Vehicle (RRPV) to conduct a Phase IV observational clinical study … [Read more…]

New facility in San Diego will support continued development of Vividion’s global discovery and clinical portfolio and pave the way for future programs aimed at bringing first-in-class therapeutics to patients in need Chemoproteomics screening capacity will increase by 50 percent to enable Vividion to pursue an expansive range of previously undrugged disease targets SAN DIEGO–(BUSINESS … [Read more…]

Company’s second-generation device further miniaturises its portable brain scanner technology to tackle the global burden of stroke SYDNEY–(BUSINESS WIRE)–EMVision (ASX: EMV), an Australian medical device company focused on the development and commercialisation of innovative portable brain scanning technology, has today unveiled its First Responder Proof of Concept device, designed for deployment via road and air … [Read more…]